PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Yazar
Hui, R.
Antonia, S. J.
Villegas, A.
Daniel, D.
Baz, D. Vincente
Murakami, S.
Yokoi, T.
Chiappori, A.
Lee, K. H.
de Wit, M.
Cho, B. C.
Bourhaba, M.
Quantin, X.
Tokito, T.
Mekhail, T.
Planchard, D.
Jiang, H.
Huang, Y.
Dennis, P. A.
Ozguroglu, M.
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]